Indraprastha Apollo Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 1996 in Delhi, India and has 710 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.